301033 迈普医学
已收盘 05-28 15:00:00
资讯
新帖
简况
5月28日迈普医学现1笔折价18.1%的大宗交易 合计成交463.6万元
证券之星 · 20分钟前
5月28日迈普医学现1笔折价18.1%的大宗交易 合计成交463.6万元
迈普医学：未单独披露止血纱产品收入
证券之星 · 05-27 15:42
迈普医学：未单独披露止血纱产品收入
迈普医学（301033）披露本次交易加期评估报告，5月26日股价下跌2.02%
证券之星 · 05-26 17:33
迈普医学（301033）披露本次交易加期评估报告，5月26日股价下跌2.02%
迈普医学（301033）披露2025年年度权益分派实施公告，5月25日股价下跌2.3%
证券之星 · 05-25 18:43
迈普医学（301033）披露2025年年度权益分派实施公告，5月25日股价下跌2.3%
股市必读：迈普医学（301033）今年截至5月21日累计跌幅已超25%
证券之星 · 05-22
股市必读：迈普医学（301033）今年截至5月21日累计跌幅已超25%
5月21日迈普医学跌7.31%，大成价值增长混合A基金重仓该股
证券之星 · 05-21
5月21日迈普医学跌7.31%，大成价值增长混合A基金重仓该股
迈普医学（301033）披露2025年度股东会决议公告，5月20日股价下跌0.53%
证券之星 · 05-20
迈普医学（301033）披露2025年度股东会决议公告，5月20日股价下跌0.53%
迈普医学（301033）披露2026年限制性股票激励计划（草案），5月19日股价上涨2.09%
证券之星 · 05-19
迈普医学（301033）披露2026年限制性股票激励计划（草案），5月19日股价上涨2.09%
迈普医学（301033）披露2025年度网上业绩说明会安排，5月18日股价下跌1.08%
证券之星 · 05-18
迈普医学（301033）披露2025年度网上业绩说明会安排，5月18日股价下跌1.08%
迈普医学：股东减持系自主决策，公司尊重股东自由安排
证券之星 · 05-15
迈普医学：股东减持系自主决策，公司尊重股东自由安排
迈普医学最新公告：股东国寿成达、深圳凯盈拟合计减持不超1.34%股份
证券之星 · 05-12
迈普医学最新公告：股东国寿成达、深圳凯盈拟合计减持不超1.34%股份
股市必读：迈普医学（301033）5月8日董秘有最新回复
证券之星 · 05-11
股市必读：迈普医学（301033）5月8日董秘有最新回复
迈普医学：主要原因系本期公司业务规模扩大，采购量相应增加
证券之星 · 05-08
迈普医学：主要原因系本期公司业务规模扩大，采购量相应增加
迈普医学：2026年脑膜相关集采全面落地执行
证券之星 · 05-08
迈普医学：2026年脑膜相关集采全面落地执行
每周股票复盘：迈普医学（301033）Q1净利降14.27%
证券之星 · 05-03
每周股票复盘：迈普医学（301033）Q1净利降14.27%
信达证券：给予迈普医学买入评级
证券之星 · 04-29
信达证券：给予迈普医学买入评级
股市必读：迈普医学年报 - 第四季度单季净利润同比增长43.08%
证券之星 · 04-29
股市必读：迈普医学年报 - 第四季度单季净利润同比增长43.08%
图解迈普医学年报：第四季度单季净利润同比增长43.08%
证券之星 · 04-28
图解迈普医学年报：第四季度单季净利润同比增长43.08%
迈普医学：本次收购交易尚处于积极推进中
证券之星 · 04-20
迈普医学：本次收购交易尚处于积极推进中
迈普医学(301033.SZ)：硬脊膜医用胶产品进入创新医疗器械特别审查程序
智通财经 · 04-15
迈普医学(301033.SZ)：硬脊膜医用胶产品进入创新医疗器械特别审查程序
暂无数据
公司概况
公司名称：
广州迈普再生医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-07-26
主营业务：
广州迈普再生医学科技股份有限公司的主营业务是医疗器械的研发、生产与销售。公司的主要产品是人工硬脑（脊）膜补片、颅颌面修补及固定系统、可吸收再生氧化纤维素、硬脑膜医用胶、3D打印设备、技术服务。
发行价格：
15.14
{"stockData":{"symbol":"301033","market":"SZ","secType":"STK","nameCN":"迈普医学","latestPrice":51.28,"timestamp":1779951810000,"preClose":51.24,"halted":0,"volume":729315,"delay":0,"changeRate":0.0008,"floatShares":56353700,"shares":67049600,"eps":1.6359,"marketStatus":"已收盘","change":0.04,"latestTime":"05-28 15:00:00","open":51,"high":51.99,"low":50.26,"amount":37189800,"amplitude":0.0338,"askPrice":51.43,"askSize":2,"bidPrice":51.28,"bidSize":26,"shortable":0,"etf":0,"ttmEps":1.6359,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780018200000},"marketStatusCode":5,"adr":0,"adjPreClose":51.24,"symbolType":"stock","openAndCloseTimeList":[[1779931800000,1779939000000],[1779944400000,1779951600000]],"highLimit":56.36,"lowLimit":46.12,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":67049620,"isCdr":false,"pbRate":4.19,"roa":"--","peRate":31.346659,"roe":"2.56%","epsLYR":1.71,"committee":-0.012987,"marketValue":3438000000,"turnoverRate":0.0129,"status":0,"floatMarketCap":2890000000},"requestUrl":"/m/hq/s/301033/tweets","defaultTab":"tweets","newsList":[{"id":"2638669418","title":"5月28日迈普医学现1笔折价18.1%的大宗交易 合计成交463.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638669418","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638669418?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:26","pubTimestamp":1779960413,"startTime":"0","endTime":"0","summary":"证券之星消息，5月28日迈普医学发生大宗交易，交易数据如下：大宗交易成交价格42元，相对当日收盘价折价18.1%，成交11.04万股，成交金额463.6万元，买方营业部为财信证券股份有限公司东莞南城证券营业部，卖方营业部为招商证券股份有限公司深圳文锦渡深润大厦证券营业部。近三个月该股共发生2笔大宗交易，合计成交1704.0手，折价成交2笔。截至2026年5月28日收盘，迈普医学报收于51.28元，上涨0.08%，换手率1.29%，成交量7293.0手，成交额3718.98万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800030874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638577688","title":"迈普医学：未单独披露止血纱产品收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2638577688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638577688?lang=zh_cn&edition=full","pubTime":"2026-05-27 15:42","pubTimestamp":1779867733,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学05月26日在投资者关系平台上答复投资者关心的问题。公司按规定在2025年年度报告第三节管理层讨论与分析之四、主营业务分析之“2、收入与成本”部分披露了分产品的营业收入情况，其中包括可吸收再生氧化纤维素及硬脑膜医用胶产品收入情况，未单独披露止血纱产品具体情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700026351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638518804","title":"迈普医学（301033）披露本次交易加期评估报告，5月26日股价下跌2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638518804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638518804?lang=zh_cn&edition=full","pubTime":"2026-05-26 17:33","pubTimestamp":1779787996,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，迈普医学报收于51.52元，较前一交易日下跌2.02%，最新总市值为34.54亿元。近日，迈普医学披露《关于本次交易所涉评估报告加期的公告》。因原评估报告评估基准日即将超过一年有效期，公司聘请联信评估以2025年11月30日为加期评估基准日进行加期评估，出具了新的评估报告。公司董事会及相关专门委员会已审议通过加期评估报告。本次交易仍以原评估报告结果作为定价依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600030162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638532146","title":"迈普医学（301033）披露2025年年度权益分派实施公告，5月25日股价下跌2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638532146","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638532146?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:43","pubTimestamp":1779705792,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，迈普医学报收于52.58元，较前一交易日下跌2.3%，最新总市值为35.25亿元。该股当日开盘53.77元，最高54.11元，最低51.71元，成交额达5591.45万元，换手率为1.89%。公司于近日披露《2025年年度权益分派实施公告》。公告显示，迈普医学2025年年度权益分派方案已获2026年5月19日召开的年度股东会审议通过。股权登记日为2026年5月29日，除权除息日为2026年6月1日。公司回购专用账户中的股份不参与本次权益分派。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637351576","title":"股市必读：迈普医学（301033）今年截至5月21日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637351576","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637351576?lang=zh_cn&edition=full","pubTime":"2026-05-22 03:50","pubTimestamp":1779393022,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，迈普医学报收于51.71元，下跌7.31%，换手率3.58%，成交量2.02万手，成交额1.09亿元。当日关注点来自交易信息汇总：迈普医学5月21日收盘报51.71元，跌7.31%，当日成交201.58万元，年内累计跌幅达25.84%。前10个交易日资金流向情况：主力资金累计净流入178.31万元，股价累计下跌9.25%；融资余额累计减少266万元，融券余量累计增加0股。资金流向5月21日主力资金净流出376.7万元；游资资金净流出559.03万元；散户资金净流入935.74万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200005147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637386318","title":"5月21日迈普医学跌7.31%，大成价值增长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637386318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637386318?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:51","pubTimestamp":1779353511,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日迈普医学跌7.31%创60日新低，收盘报51.71元，换手率3.58%，成交量2.02万手，成交额1.09亿元。重仓迈普医学的前十大公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为68.73。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为大成基金的大成价值增长混合A。该公募基金现任基金经理为杨挺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100030990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636843275","title":"迈普医学（301033）披露2025年度股东会决议公告，5月20日股价下跌0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636843275","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636843275?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:13","pubTimestamp":1779271993,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，迈普医学报收于55.79元，较前一交易日下跌0.53%，最新总市值为37.41亿元。该股当日开盘55.66元，最高56.76元，最低55.0元，成交额达6506.98万元，换手率为2.07%。公司于近日披露《2025年度股东会决议公告》。表决结果显示各项议案均获有效通过，无否决或变更情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636837194","title":"迈普医学（301033）披露2026年限制性股票激励计划（草案），5月19日股价上涨2.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636837194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636837194?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:10","pubTimestamp":1779185428,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，迈普医学报收于56.09元，较前一交易日上涨2.09%，最新总市值为37.61亿元。该股当日开盘56.45元，最高58.67元，最低55.14元，成交额达1.12亿元，换手率为3.5%。公司于近日披露《2026年限制性股票激励计划（草案）》，拟授予限制性股票176.10万股，占公司股本总额的2.63%，授予对象为公司董事、高级管理人员、中层管理人员及核心技术业务骨干共59人，不包括独立董事及持股5%以上股东。该计划尚需提交公司股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900034919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636024903","title":"迈普医学（301033）披露2025年度网上业绩说明会安排，5月18日股价下跌1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636024903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636024903?lang=zh_cn&edition=full","pubTime":"2026-05-18 18:07","pubTimestamp":1779098829,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，迈普医学报收于54.94元，较前一交易日下跌1.08%，最新总市值为36.84亿元。该股当日开盘55.08元，最高56.36元，最低54.58元，成交额达4813.57万元，换手率为1.55%。近日，广州迈普再生医学科技股份有限公司发布《关于举办2025年度网上业绩说明会的公告》。公告显示，公司已于2026年4月28日在巨潮资讯网披露《2025年年度报告》及摘要，并将于2026年5月22日15:00-16:00通过“价值在线”平台举办2025年度网上业绩说明会，以网络互动方式与投资者交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800028730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635082752","title":"迈普医学：股东减持系自主决策，公司尊重股东自由安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2635082752","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635082752?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:52","pubTimestamp":1778849530,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学05月14日在投资者关系平台上答复投资者关心的问题。股东减持计划及减持时点，系股东基于自身经营管理规划作出的自主决策，二级市场交易的行为公司尊重股东的自由安排。公司一直秉承对投资者回报的高度重视，坚持为投资者提供持续、稳定的现金分红回报，利润分配方案由公司股东会审议通过之后执行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500041139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634113142","title":"迈普医学最新公告：股东国寿成达、深圳凯盈拟合计减持不超1.34%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2634113142","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634113142?lang=zh_cn&edition=full","pubTime":"2026-05-12 20:30","pubTimestamp":1778589012,"startTime":"0","endTime":"0","summary":"迈普医学(301033.SZ)公告称，首发前股东国寿成达(上海)健康产业股权投资中心(有限合伙)计划减持不超过60.14万股(占公司总股本的0.8969%)，持股5%以上股东深圳市凯盈科技有限公司计划减持不超过30万股(占公司总股本的0.4474%)。减持方式均为集中竞价交易，减持期间为公告披露之日起15个交易日后的3个月内，减持原因为自身经营需要。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200037416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634429964","title":"股市必读：迈普医学（301033）5月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2634429964","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634429964?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:06","pubTimestamp":1778443575,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，迈普医学报收于57.22元，上涨2.88%，换手率3.33%，成交量1.88万手，成交额1.07亿元。董秘最新回复投资者： 2022-2025年，公司人工硬脑膜补片营收占比由74.09%降至42.36%，止血类新产品营收占比自2.76%升至28.51%。投资者： 公司2025年脑膜系列产品合计实现销售收入15,623.79万元，2024年脑膜系列产品合计实现销售收入15,559.38 万元，基本没有增长。2026 年随着脑膜相关集采全面落地执行，产品市场渗透率有望进一步提高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633488256","title":"迈普医学：主要原因系本期公司业务规模扩大，采购量相应增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2633488256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633488256?lang=zh_cn&edition=full","pubTime":"2026-05-08 11:37","pubTimestamp":1778211426,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学(301033)05月08日在投资者关系平台上答复投资者关心的问题。投资者提问：公司一季报的现金流量表里面的 购买商品、接受劳务支付的现金比往年同期大幅增加1400万元左右，请问主要的原因是什么？迈普医学回复：尊敬的投资者，您好！主要原因系本期公司业务规模扩大，采购量相应增加。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800017446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633848822","title":"迈普医学：2026年脑膜相关集采全面落地执行","url":"https://stock-news.laohu8.com/highlight/detail?id=2633848822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633848822?lang=zh_cn&edition=full","pubTime":"2026-05-08 11:35","pubTimestamp":1778211323,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学05月08日在投资者关系平台上答复投资者关心的问题。投资者提问：公司2025年脑膜系列产品合计实现销售收入15,623.79万元，2024年脑膜系列产品合计实现销售收入15,559.38 万元，基本没有增长。请披露一下2025年全国医院的脑膜系列产品的需求总额？近几年脑膜集采区域不断扩大，公司脑膜市场销量不断提升。2026 年随着脑膜相关集采全面落地执行，产品市场渗透率有望进一步提高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800017265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632001670","title":"每周股票复盘：迈普医学（301033）Q1净利降14.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632001670","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632001670?lang=zh_cn&edition=full","pubTime":"2026-05-03 07:43","pubTimestamp":1777765387,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，迈普医学报收于55.06元，较上周的56.47元下跌2.5%。本周，迈普医学4月29日盘中最高价报57.5元。业绩披露要点：2026年一季度归母净利润2071.54万元，同比下降14.27%。股本股东变化截至2026年3月31日，迈普医学股东户数为7567.0户，较2025年末增加1461.0户，增幅23.93%。业绩披露要点2026年一季报显示，公司主营收入7836.28万元，同比增长6.32%；归母净利润2071.54万元，同比下降14.27%；扣非净利润1952.56万元，同比下降14.83%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631951715","title":"信达证券：给予迈普医学买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2631951715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631951715?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:30","pubTimestamp":1777469431,"startTime":"0","endTime":"0","summary":"信达证券股份有限公司唐爱金近期对迈普医学进行研究并发布了研究报告《新品放量驱动高增长，Q1短期承压不改全年增长趋势》，给予迈普医学买入评级。 迈普医学 事件：公司发布2025年年报及2026年一季报。2026Q1业绩短期承压，主要系脑膜及止血纱集采政策落地晚于预期，渠道在一季度处于去库存状态所致。公司持续高强度研发投入，2025年研发投入0.50亿元，占营收比重达13.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900064579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601059","301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631553782","title":"股市必读：迈普医学年报 - 第四季度单季净利润同比增长43.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631553782","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631553782?lang=zh_cn&edition=full","pubTime":"2026-04-29 06:55","pubTimestamp":1777416958,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，迈普医学报收于54.92元，下跌2.31%，换手率4.7%，成交量2.65万手，成交额1.43亿元。股本股东变化股东户数变动近日迈普医学披露，截至2026年3月31日公司股东户数为7567.0户，较12月31日增加1461.0户，增幅为23.93%。公司公告汇总内部控制审计报告华兴会计师事务所对广州迈普再生医学科技股份有限公司截至2025年12月31日的财务报告内部控制有效性进行了审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900017022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630316026","title":"图解迈普医学年报：第四季度单季净利润同比增长43.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630316026","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630316026?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:01","pubTimestamp":1777309260,"startTime":"0","endTime":"0","summary":"证券之星消息，迈普医学2025年年报显示，当年度公司主营收入3.69亿元，同比上升32.46%；归母净利润1.13亿元，同比上升43.47%；扣非净利润1.05亿元，同比上升54.8%；其中2025年第四季度，公司单季度主营收入1.2亿元，同比上升36.69%；单季度归母净利润3727.44万元，同比上升43.08%；单季度扣非净利润3264.62万元，同比上升48.22%；负债率10.87%，投资收益293.81万元，财务费用-82.18万元，毛利率80.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800002798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628710635","title":"迈普医学：本次收购交易尚处于积极推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2628710635","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628710635?lang=zh_cn&edition=full","pubTime":"2026-04-20 15:39","pubTimestamp":1776670748,"startTime":"0","endTime":"0","summary":"投资者提问：您好，根据公司公开披露信息提问：1.公司收购易介医疗问询函显示，其一年半内95家经销商退出，请问退出经销商的库存、货款是否妥善处理，有无未结纠纷？本次收购交易尚处于积极推进中，如达到信息披露要求，公司将严格按照有关法律法规的要求履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000015643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301033","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627029464","title":"迈普医学(301033.SZ)：硬脊膜医用胶产品进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2627029464","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627029464?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:45","pubTimestamp":1776242701,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈普医学(301033.SZ)公告，公司自主研发的硬脊膜医用胶产品于近日获国家药品监督管理局医疗器械技术审评中心同意，进入创新医疗器械特别审查程序。硬脊膜医用胶适用于硬脊膜缝合部位的辅助封合，防止脑脊液渗漏。本产品以亲电亲核反应为基础，通过全球领先的专利技术配方以及辅助配件，在术中高效完成硬脊膜缝合部位的即时封堵。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","159883","BK1222","09996","BK1583","301033","BK0251","BK1100","09997"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779961578229,"stockEarnings":[{"period":"1week","weight":-0.0816},{"period":"1month","weight":-0.0886},{"period":"3month","weight":-0.2939},{"period":"6month","weight":-0.228},{"period":"1year","weight":-0.1935},{"period":"ytd","weight":-0.2409}],"compareEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.0128},{"period":"6month","weight":0.0528},{"period":"1year","weight":0.2254},{"period":"ytd","weight":0.0315}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州迈普再生医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"7567人(较上一季度增加23.93%)","perCapita":"7447股","listingDate":"2021-07-26","address":"广东省广州市黄埔区崖鹰石路3号","registeredCapital":"6704万元","survey":" 广州迈普再生医学科技股份有限公司的主营业务是医疗器械的研发、生产与销售。公司的主要产品是人工硬脑（脊）膜补片、颅颌面修补及固定系统、可吸收再生氧化纤维素、硬脑膜医用胶、3D打印设备、技术服务。","listedPrice":15.14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈普医学,301033,迈普医学股票,迈普医学股票老虎,迈普医学股票老虎国际,迈普医学行情,迈普医学股票行情,迈普医学股价,迈普医学股市,迈普医学股票价格,迈普医学股票交易,迈普医学股票购买,迈普医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈普医学(301033)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈普医学(301033)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}